Assessment of serum soluble CD40 ligand levels in patients with chronic rhinosinusitis

Assessment of serum soluble CD40 ligand levels in patients with chronic rhinosinusitis

Chronic rhinosinusitis (CRS) is a disease highly associated with abnormal regulation of T and B cells. The underlying pathophysiology of inflammatory pathways has critical implications for the diagnosis and management of CRS. Soluble CD40-ligand (sCD40L) is a cleaved form of CD40L present in plasma...

Full description

Bibliographic Details
Main Authors:	Zhichen Liu, MD, Yuhui Fan, MD, Aina Zhou, MD, Jisheng Liu, MD, Qingqing Jiao, PhD
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	World Allergy Organization Journal
Subjects:	Chronic rhinosinusitis (CRS) Eosinophilic chronic rhinosinusitis (eCRS) Soluble CD40-Ligand (sCD40L) CD40L Inflammatory biomarker
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455124000115

Similar Items

Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
by: Aina Zhou, et al.
Published: (2023-06-01)

Reduced Relapse-Free Survival in Colorectal Cancer Patients with Elevated Soluble CD40 Ligand Levels Improved by Vitamin D Supplementation
by: Hiroshi Fujimoto, et al.
Published: (2023-10-01)

Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
by: Kotb Abbass Metwalley, et al.
Published: (2020-06-01)

Inflammation and Endotyping in Chronic Rhinosinusitis—A Paradigm Shift
by: Sinead Ahern, et al.
Published: (2019-04-01)

Distinct Gene Set Enrichment Profiles in Eosinophilic and Non-Eosinophilic Chronic Rhinosinusitis with Nasal Polyps by Bulk RNA Barcoding and Sequencing
by: Takashi Ishino, et al.
Published: (2022-05-01)

Preoperative soluble cluster of differentiation 40 ligand level is associated with outcome of pulmonary endarterectomyCentral MessagePerspective
by: Ayako Shigeta, MD, PhD, et al.
Published: (2021-12-01)

Oncostatin M’s Involvement in the Pathogenesis of Chronic Rhinosinusitis: Focus on Type 1 and 2 Inflammation
by: Chie Ishikawa, et al.
Published: (2023-12-01)

Cell-Based Models of ‘Cytokine Release Syndrome’ Endorse CD40L and Granulocyte–Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy
by: Ala Dibas, et al.
Published: (2023-11-01)

Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients
by: Bożena Chodynicka, et al.
Published: (2012-04-01)

The Role of Exosomes in the Pathophysiology of Chronic Rhinosinusitis
by: Sarina K. Mueller
Published: (2022-01-01)

Effect of sCD40L Combined with Vinorelbine on Lung Adenocarcinoma Cell A549
by: Shan LIU, et al.
Published: (2010-07-01)

PROGNOSTIC VALUE OF SOLUBLE CD40 LIGAND AFTER LIVER TRANSPLANTATION IN CHILDREN WITH CONGENITAL AND HEREDITARY DISEASES OF HEPATOBILIARY SYSTEM
by: O. P. Shevchenko, et al.
Published: (2012-05-01)

CD40–CD40L in Neurological Disease
by: Heather D. Ots, et al.
Published: (2022-04-01)

Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents
by: Aynur Küçükçongar Yavaş, et al.
Published: (2017-03-01)

Multiple reasons underlaying uncontrolled disease in the majority of chronic rhinosinusitis patients
by: An-Sofie Viskens, et al.
Published: (2022-12-01)

p63+Krt5+ basal cells are increased in the squamous metaplastic epithelium of patients with radiation-induced chronic Rhinosinusitis
by: Hongming Huang, et al.
Published: (2020-09-01)

Soluble CD40 Levels in Plasma Are Associated with Cardiovascular Disease and in Carotid Plaques with a Vulnerable Phenotype
by: Annelie Shami, et al.
Published: (2021-09-01)

Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet’s disease
by: Sandro Félix Perazzio, et al.
Published: (2017-10-01)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
by: Mustafa Begenc Tascanov, et al.
Published: (2019-07-01)

Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
by: T V Popkova, et al.
Published: (2008-05-01)

Persistently higher serum sCD40L levels are associated with outcome in septic patients
by: Yingjian Liang, et al.
Published: (2021-01-01)

Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review
by: Samuel J. M. Hale, et al.
Published: (2022-06-01)

The Role of Corticosteroid Nasal Irrigations in the Management of Chronic Rhinosinusitis: A State-of-the-Art Systematic Review
by: Christian Calvo-Henriquez, et al.
Published: (2023-05-01)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
by: Wim Adriaensen, et al.
Published: (2018-12-01)

Predictive value of soluble CD40L combined with APACHE II score in elderly patients with sepsis in the emergency department
by: Long Yang, et al.
Published: (2024-01-01)

CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
by: Steffen Daub, et al.
Published: (2020-11-01)

Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps
by: Shreya P. Ramkumar, et al.
Published: (2023-03-01)

RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse
by: Yizhi Chen, et al.
Published: (2023-06-01)

Of mice and men: airway hyperreactivity requires CD40L but not IgE
by: O'Brien Chritopher, et al.
Published: (2001-02-01)

Serum YKL-40 Levels Predict Endotypes and Associate with Postoperative Recurrence in Patients with Chronic Rhinosinusitis with Nasal Polyps
by: Wen S, et al.
Published: (2021-10-01)

Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020-02-01)

CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses
by: Christiane L. Schnabel, et al.
Published: (2022-04-01)

The role of CD40 receptor-ligand system in the development of diabetes mellitus and its complications
by: Irina Arkad'evna Bondar', et al.
Published: (2011-09-01)

Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy
by: Kundan Solanki, et al.
Published: (2023-01-01)

Rola szlaku CD40/CD40L w biologicznej aktywności płytek krwi. Część I
by: Karolina Królewska, et al.
Published: (2010-10-01)

Rola szlaku CD40/CD40L w biologicznej aktywności płytek krwi. Część II
by: Joanna Saluk-Juszczak, et al.
Published: (2010-12-01)

Clinical Detection of Chronic Rhinosinusitis through Next-Generation Sequencing of the Oral Microbiota
by: Ben-Chih Yuan, et al.
Published: (2020-06-01)

Serum Soluble CD40 Ligand in Predicting Simple Appendicitis and Complicated Appendicitis at Different Time Points in Children
by: Wun-Yan Huang, et al.
Published: (2021-06-01)

The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis
by: Steven Perrin, et al.
Published: (2022-04-01)

Serum CD40 ligand levels and persistent lone atrial fibrillation
by: Timuçin Altın
Published: (2016-07-01)